Skip to main content
BIO-FD&C CO.,LTD. logo

BIO-FD&C CO.,LTD. — Investor Relations & Filings

Ticker · 251120 ISIN · KR7251120002 KO Manufacturing
Filings indexed 95 across all filing types
Latest filing 2024-11-12 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 251120

About BIO-FD&C CO.,LTD.

https://www.biofdnc.com/?lang=en

BIO-FD&C CO.,LTD. is a biotechnology company specializing in research and development based on a proprietary, sustainable plant cell platform technology. The company develops and commercializes high-value active ingredients for the cosmetics, pharmaceutical, and food industries. Its product portfolio includes plant cell-derived materials, bioactive recombinant proteins, growth factors, and peptides, with a significant focus on anti-aging ingredients for cosmeceuticals. Leveraging advanced techniques such as bioreactor cultivation, radiofrequency-enhanced production of bioactive compounds (SMART-RC2), and plant cell cryopreservation, the company is also exploring the development of plant cell-based therapeutics, including antibodies and vaccines.

Recent filings

Filing Released Lang Actions
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 바이오에프디엔씨' covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial information, business operations, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-12 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) for the company BioFD&C. It details the voting outcomes for the appointment of directors (사내이사 선임의 건), which were approved as proposed. This falls under the category of Declaration of Voting Results.
2024-10-14 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for BioFD&C. It includes the meeting date, location, agenda items (election of directors), and detailed management reference materials (경영참고사항) regarding business status and director candidates. This is a standard proxy solicitation document sent to shareholders to inform them of an upcoming meeting and request their votes, which falls under the Proxy Solicitation & Information Statement category.
2024-09-13 Korean
주주총회소집결의 (임시주주총회)
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company 'BioFD&C'. It details the date, time, location, and the specific agenda items (election of directors). This type of document is a standard proxy solicitation or notice of meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2024-08-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the setting of a record date for a shareholder register closure in preparation for an Extraordinary General Meeting. It does not contain the full proxy materials or the meeting results themselves, but rather serves as a formal regulatory announcement of a corporate action. Given it is a standard regulatory filing regarding meeting logistics, it falls under the RNS category.
2024-08-19 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Bio-FD&C' for the period ending June 30, 2024. It contains comprehensive financial data, business descriptions, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.